REGN
Regeneron Pharmaceuticals, Inc.
NMS
$602.92
+2.26
(+0.38%)
Deep pullback · -2.83σ
Hot zone
Grade C
Valuation
Market cap
$63.2B
P/E (ttm)
14.7
Forward P/E
11.2
Beta (5y)
0.30
Shares out
103.0M
Div yield
62.00%
Profitability & returns
ROE
14.5%
Net margin
29.6%
FCF margin
21.9%
Debt / equity
0.09
Trading information
Last price
$602.92
Day range
$602.92 – $602.92
52-wk range
$591.52 – $821.11
Avg volume
0.8M
RSI (2)
18.5
TAO zone
Deep pullback
Company
Sector
Healthcare
Industry
Biotechnology
Exchange
NMS
Next earnings
2026-07-30
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic mac…